Categories
Archives
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
Other Sites
- tummy tuck cost
- tummy tuck surgery
- breast enhancement
- saline breast implants
- Affordable medical tourism
- Boob job cost
- lower blepharoplasty
- What is medical tourism
- medical tourism companies
- breast augmentation surgery
- Calf implants
- Breast lift and augmentation
- abdominoplasty surgery cost
- breast enlargement surgery
- How much do breast implants cost
- body contouring surgery
- breast implant cost
- celebrity plastic surgery
- how much are breast implants
- The Truth about Silicone Breast Implants
Category Archives: Multiple Sclerosis Research
FDA warns about 'liberation therapy' for multiple sclerosis
Published on May 11, 2012 at 11:45 AM FDA issues alert on potential dangers of unproven treatment for multiple sclerosis The U.S. Continue reading
Posted in Multiple Sclerosis Research
Tagged adverse-event, been-adequately, brain, ccsvi, experimental, fda, from-the-brain, informed-as-new, keep-the-public, often-the-nerve, procedure, safety, source
Comments Off
Ist Annual Multiple Sclerosis a success
Readmore: Local, MS, Walk Over one hundred and twenty-five people walked in support of new multiple sclerosis programs, services and research today. This was the first annual MS walk in Jefferson City and the gateway area chapter urges anyone interested to join their society which helps those currently living with multiple sclerosis and supports finding a cure for the disease. Continue reading
Posted in Multiple Sclerosis Research
Tagged a-cure-for, and-twenty-five, first-annual, gateway, gateway-area, jefferson-city, local, people-walked, services-and, the-disease-, with-multiple
Comments Off
FDA warns MS patients about risky treatment
WASHINGTON (Reuters) – U.S. drug regulators are warning people with multiple sclerosis that an experimental treatment that props open internal veins in the neck and chest can cause death or serious injury. The Food and Drug Administration on Thursday said at least two people had died from the procedure, which uses stents or balloon angioplasties to widen veins that connect the brain and spinal … Continue reading
Posted in Multiple Sclerosis Research
Tagged and-chest, are-warning, drug-regulators, internal-veins, least-two, neck, props-open, said-at-least, which-uses
Comments Off
FDA Issues Warning on Controversial MS Treatment
THURSDAY, May 10 (HealthDay News) — Doctors and patients need to be aware of the potential risk of injuries and death associated with an experimental treatment for multiple sclerosis called liberation therapy, the U.S. Food and Drug Administration said in an alert issued Thursday. Continue reading
Posted in Multiple Sclerosis Research
Tagged alert-issued, and-patients, called-liberation, death-associated, doctors, injuries-and, multiple-sclerosis, potential, the-potential, thursday, treatment-for
Comments Off
Autoimmune Disorders Therapeutics Market to 2017 – Launch of Gilenya and Benlysta to Drive the Growth of Multiple …
NEW YORK, May 10, 2012 /PRNewswire/ — Reportlinker.com announces that a new market research report is available in its catalogue: http://www.reportlinker.com/p0850351/Autoimmune-Disorders-Therapeutics-Market-to-2017—Launch-of-Gilenya-and-Benlysta-to-Drive-the-Growth-of-Multiple-Sclerosis-and-Systemic-Lupus-Erythematosus-Therapeutic-Segments.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Therapy Autoimmune Disorders Therapeutics Market to 2017 – Launch of Gilenya and Benlysta to Drive the Growth of Multiple Sclerosis and Systemic Lupus Erythematosus Therapeutic Segments GBI Research’s analysis shows that the autoimmune disorders therapeutics market, comprising RA, MS, psoriasis, IBDs (CD and UC) and SLE, was worth $16.9 billion in 2002 and grew at a Compound Annual Growth Rate (CAGR) of 7.5% to $30.2 billion in 2010. It is forecast to reach $61.4 billion in 2017, indicating a CAGR of 10.7% during the forecast period Continue reading
FDA warns about multiple sclerosis vein procedure
The U.S. Continue reading
Posted in Multiple Sclerosis Research
Tagged and-experimental, for-people, has-issued, vein-procedure, with-multiple
Comments Off
Multiple Sclerosis Walk in Joplin
The national Multiple Sclerosis Society held it’s 20th annual ‘Walk MS Joplin’ event at Landreth park Saturday. Continue reading
Posted in Multiple Sclerosis Research
Tagged a-step-closer, and-services, clients, cure, disease, for-programs, money-raised, organizers, ozarks, step-closer
Comments Off
MS questions and answers
The Elk Grove MS Group will be hosting the number one authority in Multiple Sclerosis (MS) research in northern California, Dr. John Schaefer. Continue reading
Posted in Multiple Sclerosis Research
Tagged article, california, church, clientsstudents, education, generosity, medicine, neurology, professor, topics, university
Comments Off
Hundreds Walk For Multiple Sclerosis Research
Shannon Ballard sballard@kjct8.com Copyright 2010 KJCT. All rights reserved Continue reading
Posted in Multiple Sclerosis Research
Tagged copyright, kjct, material, material-may, rights-reserved-, shannon, shannon-ballard
Comments Off